4//SEC Filing
Casten Richard S 4
Accession 0001192482-21-000241
CIK 0001780097other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 8:24 PM ET
Size
10.5 KB
Accession
0001192482-21-000241
Insider Transaction Report
Form 4
Baudax Bio, Inc.BXRX
Casten Richard S
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2021-03-08+15,000→ 15,000 totalExercise: $1.21Exp: 2031-03-08→ Common Stock (15,000 underlying) - Award
Common Stock
2021-03-08+15,000→ 15,000 total - Award
Common Stock
2021-03-08+85,000→ 100,000 total - Award
Stock Option (right to buy)
2021-03-08+255,000→ 255,000 totalExercise: $1.21Exp: 2031-03-08→ Common Stock (255,000 underlying)
Footnotes (4)
- [F1]These restricted stock units will vest in full on December 31, 2021, subject to continued service with the Company.
- [F2]These restricted stock units will vest in four equal annual installments beginning on March 8, 2022, subject to continued service with the Company.
- [F3]The stock option will vest in full on December 31, 2021, subject to continued service with the Company.
- [F4]The stock option vests in equal monthly installments over 48 months, beginning on April 8, 2021, subject to continued service to the Company.
Documents
Issuer
Baudax Bio, Inc.
CIK 0001780097
Entity typeother
Related Parties
1- filerCIK 0001850307
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 8:24 PM ET
- Size
- 10.5 KB